{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:13:03Z","timestamp":1772025183680,"version":"3.50.1"},"update-to":[{"DOI":"10.1038\/s41598-018-34393-9","type":"expression_of_concern","label":"Expression of concern","source":"retraction-watch","updated":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"record-id":"35602"}],"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:00:00Z","timestamp":1540771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:00:00Z","timestamp":1540771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There is insufficient evidence to support screening of various tick-borne diseases (TBD) related microbes alongside Borrelia in patients suffering from TBD. To evaluate the involvement of multiple microbial immune responses in patients experiencing TBD we utilized enzyme-linked immunosorbent assay. Four hundred and thirty-two human serum samples organized into seven categories followed Centers for Disease Control and Prevention two-tier Lyme disease (LD) diagnosis guidelines and Infectious Disease Society of America guidelines for post-treatment Lyme disease syndrome. All patient categories were tested for their immunoglobulin M (IgM) and G (IgG) responses against 20 microbes associated with TBD. Our findings recognize that microbial infections in patients suffering from TBDs do not follow the one microbe, one disease Germ Theory as 65% of the TBD patients produce immune responses to various microbes. We have established a causal association between TBD patients and TBD associated co-infections and essential opportunistic microbes following Bradford Hill\u2019s criteria. This study indicated an 85% probability that a randomly selected TBD patient will respond to Borrelia and other related TBD microbes rather than to Borrelia alone. A paradigm shift is required in current healthcare policies to diagnose TBD so that patients can get tested and treated even for opportunistic infections.<\/jats:p>","DOI":"10.1038\/s41598-018-34393-9","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T10:18:01Z","timestamp":1540289881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["RETRACTED ARTICLE: Evaluating polymicrobial immune responses in patients suffering from tick-borne diseases"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4346-027X","authenticated-orcid":false,"given":"Kunal","family":"Garg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leena","family":"Meril\u00e4inen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole","family":"Franz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3820-612X","authenticated-orcid":false,"given":"Heidi","family":"Pirttinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Quevedo-Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Croucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leona","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,29]]},"reference":[{"key":"34393_CR1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/healthcare6010016","volume":"6","author":"M Davidsson","year":"2018","unstructured":"Davidsson, M. The Financial Implications of a Well-Hidden and Ignored Chronic Lyme Disease Pandemic. Healthcare. 6, 16 (2018).","journal-title":"Healthcare."},{"key":"34393_CR2","doi-asserted-by":"crossref","first-page":"96.e1","DOI":"10.1016\/j.cmi.2014.07.004","volume":"21","author":"L Lempereur","year":"2015","unstructured":"Lempereur, L. et al. A retrospective serological survey on human babesiosis in Belgium. Clin Microbiol Infec. 21, 96.e1\u201396.e7 (2015).","journal-title":"Clin Microbiol Infec."},{"key":"34393_CR3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3201\/eid1603.081685","volume":"16","author":"E Angelakis","year":"2010","unstructured":"Angelakis, E., Billeter, S. A., Breitschwerdt, E. B., Chomel, B. B. & Raoult, D. Potential for Tick-borne Bartonelloses. Emerg Infect Dis. 16, 385\u2013391 (2010).","journal-title":"Emerg Infect Dis."},{"key":"34393_CR4","doi-asserted-by":"crossref","first-page":"755","DOI":"10.14202\/vetworld.2015.755-762","volume":"8","author":"J Kioko","year":"2015","unstructured":"Kioko, J., Baker, J., Shannon, A. & Kiffner, C. Ethnoecological knowledge of ticks and treatment of tick-borne diseases among Maasai people in Northern Tanzania. Vet World. 8, 755\u2013762 (2015).","journal-title":"Vet World."},{"key":"34393_CR5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1089\/vbz.2015.1815","volume":"15","author":"KP Jasik","year":"2015","unstructured":"Jasik, K. P. et al. Congenital Tick Borne Diseases: Is This An Alternative Route of Transmission of Tick-Borne Pathogens In Mammals? Vector Borne Zoonotic Dis. 15, 637\u2013644 (2015).","journal-title":"Vector Borne Zoonotic Dis."},{"key":"34393_CR6","first-page":"113","volume":"29","author":"A Gudoshnik","year":"1958","unstructured":"Gudoshnik, A. Role of pasture ticks and rodents in dissemination of Brucella. Zh Mikrobiol Epidemiol Immunobiol. 29, 113\u20137 (1958).","journal-title":"Zh Mikrobiol Epidemiol Immunobiol."},{"key":"34393_CR7","first-page":"430","volume":"269","author":"RW Colman","year":"1963","unstructured":"Colman, R. W. Tick-Borne Brucellosis. New Engl J Med. 269, 430\u2013430 (1963).","journal-title":"New Engl J Med."},{"key":"34393_CR8","doi-asserted-by":"crossref","unstructured":"Wang, Q. et al. Brucella melitensis and B. abortus in eggs, larvae and engorged females of Dermacentor marginatus. Ticks Tick Borne Dis. 9 (2018).","DOI":"10.1016\/j.ttbdis.2018.03.021"},{"key":"34393_CR9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cll.2009.10.004","volume":"30","author":"N Ismail","year":"2010","unstructured":"Ismail, N., Bloch, K. C. & McBride, J. W. Human Ehrlichiosis and Anaplasmosis. Clin Lab Med. 30, 261\u2013292 (2010).","journal-title":"Clin Lab Med."},{"key":"34393_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-3305-6-1","volume":"6","author":"X-B Wu","year":"2013","unstructured":"Wu, X.-B., Na, R.-H., Wei, S.-S., Zhu, J.-S. & Peng, H.-J. Distribution of tick-borne diseases in China. Parasit Vectors. 6, 1\u20138 (2013).","journal-title":"Parasit Vectors."},{"key":"34393_CR11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ttbdis.2015.12.010","volume":"7","author":"J Koetsveld","year":"2016","unstructured":"Koetsveld, J., Tijsse-Klasen, E., Herremans, T., Hovius, J. W. & Sprong, H. Serological and molecular evidence for spotted fever group Rickettsia and Borrelia burgdorferi sensu lato co-infections in The Netherlands. Ticks Tick Borne Dis. 7, 371\u20137 (2016).","journal-title":"Ticks Tick Borne Dis."},{"key":"34393_CR12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ttbdis.2013.07.009","volume":"5","author":"P Lindblom","year":"2014","unstructured":"Lindblom, P. et al. Tick-borne encephalitis virus in ticks detached from humans and follow-up of serological and clinical response. Ticks Tick Borne Dis. 5, 21\u20138 (2014).","journal-title":"Ticks Tick Borne Dis."},{"key":"34393_CR13","first-page":"247","volume":"46","author":"E Ba\u015fbulut","year":"2012","unstructured":"Ba\u015fbulut, E. et al. Seroprevalence of Borrelia burgdorferi and tick-borne encephalitis virus in a rural area of Samsun, Turkey. Mikrobiyol B\u00fcl. 46, 247\u201356 (2012).","journal-title":"Mikrobiyol B\u00fcl."},{"key":"34393_CR14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/00365549009027051","volume":"22","author":"R Gustafson","year":"2009","unstructured":"Gustafson, R., Svenungsson, B., Gardulf, A., Stiernstedt, G. & Forsgren, M. Prevalence of Tick-borne Encephalitis and Lyme Borreliosis in a Defined Swedish Population. Scand J Infect Dis. 22, 297\u2013306 (2009).","journal-title":"Scand J Infect Dis."},{"key":"34393_CR15","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.1996.03530450047031","volume":"275","author":"P Krause","year":"1996","unstructured":"Krause, P. et al. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA. 275, 1657\u201360 (1996).","journal-title":"JAMA."},{"key":"34393_CR16","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/368187","volume":"36","author":"A Steere","year":"2003","unstructured":"Steere, A. et al. Prospective study of coinfection in patients with erythema migrans. Clin Infect Dis. 36, 1078\u201381 (2003).","journal-title":"Clin Infect Dis."},{"key":"34393_CR17","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1128\/CVI.00308-07","volume":"14","author":"D Grab","year":"2007","unstructured":"Grab, D., Nyarko, E., Barat, N., Nikolskaia, O. & Dumler, J. Anaplasma phagocytophilum-Borrelia burgdorferi Coinfection Enhances Chemokine, Cytokine, and Matrix Metalloprotease Expression by Human Brain Microvascular Endothelial Cells. Clin Vaccine Immunol. 14, 1420\u20131424 (2007).","journal-title":"Clin Vaccine Immunol."},{"key":"34393_CR18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1574-695X.1994.tb00437.x","volume":"8","author":"J Chiao","year":"1994","unstructured":"Chiao, J. et al. Antigens of Lyme disease of spirochaete Borrelia burgdorferi inhibits antigen or mitogen-induced lymphocyte proliferation. FEMS Immunol Med Microbiol. 8, 151\u20135 (1994).","journal-title":"FEMS Immunol Med Microbiol."},{"issue":"Suppl 1","key":"34393_CR19","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1086\/516163","volume":"25","author":"E Aberer","year":"1997","unstructured":"Aberer, E., Koszik, F. & Silberer, M. Why is chronic Lyme borreliosis chronic? Clin Infect Dis 25(Suppl 1), S64\u201370 (1997).","journal-title":"Clin Infect Dis"},{"key":"34393_CR20","doi-asserted-by":"crossref","first-page":"e84980","DOI":"10.1371\/journal.pone.0084980","volume":"8","author":"Y Chung","year":"2013","unstructured":"Chung, Y., Zhang, N. & Wooten, R. Borrelia burgdorferi elicited-IL-10 suppresses the production of inflammatory mediators, phagocytosis, and expression of co-stimulatory receptors by murine macrophages and\/or dendritic cells. PloS One. 8, e84980 (2013).","journal-title":"PloS One."},{"key":"34393_CR21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2249.2006.03245.x","volume":"147","author":"S Jarefors","year":"2007","unstructured":"Jarefors, S., Janefjord, C., Forsberg, P., Jenmalm, M. & Ekerfelt, C. Decreased up-regulation of the interleukin-12Rbeta2-chain and interferon-gamma secretion and increased number of forkhead box P3-expressing cells in patients with a history of chronic Lyme borreliosis compared with asymptomatic Borrelia-exposed individuals. Clin Exp Immunol. 147, 18\u201327 (2007).","journal-title":"Clin Exp Immunol."},{"key":"34393_CR22","doi-asserted-by":"crossref","first-page":"e1004976","DOI":"10.1371\/journal.ppat.1004976","volume":"11","author":"R Elsner","year":"2015","unstructured":"Elsner, R., Hastey, C., Olsen, K. & Baumgarth, N. Suppression of Long-Lived Humoral Immunity Following Borrelia burgdorferi Infection. PLoS Pathog. 11, e1004976 (2015).","journal-title":"PLoS Pathog."},{"key":"34393_CR23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/IAI.02471-14","volume":"83","author":"RA Elsner","year":"2015","unstructured":"Elsner, R. A., Hastey, C. J. & Baumgarth, N. CD4+ T cells promote antibody production but not sustained affinity maturation during Borrelia burgdorferi infection. Infect Immun. 83, 48\u201356 (2015).","journal-title":"Infect Immun."},{"key":"34393_CR24","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/1874205X01206010158","volume":"6","author":"W Berghoff","year":"2012","unstructured":"Berghoff, W. Chronic Lyme Disease and Co-infections: Differential Diagnosis. Open Neurol J. 6, 158\u201378 (2012).","journal-title":"Open Neurol J."},{"key":"34393_CR25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF02230357","volume":"15","author":"O Lesnyak","year":"1996","unstructured":"Lesnyak, O., Sokolova, L., Starikova, T., Fadeeva, M. & Beikin, Y. Does chlamydia trachomatis influence manifestations of lyme arthritis? Clin Rheumatol. 15, 353\u2013357 (1996).","journal-title":"Clin Rheumatol."},{"key":"34393_CR26","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/ard.60.6.632","volume":"60","author":"N Putschky","year":"2001","unstructured":"Putschky, N., Schnarr, S., Wollenhaupt, J., Zeidler, H. & Kuipers, J. Intra-articular co-infection by Borrelia burgdorferi and Chlamydia trachomatis. Ann Rheum Dis. 60, 632\u2013634 (2001).","journal-title":"Ann Rheum Dis."},{"key":"34393_CR27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/IJGM.S75825","volume":"8","author":"P Mayne","year":"2014","unstructured":"Mayne, P. Clinical determinants of Lyme borreliosis, babesiosis, bartonellosis, anaplasmosis, and ehrlichiosis in an Australian cohort. Int J Gen Medicine. 8, 15\u201326 (2014).","journal-title":"Int J Gen Medicine."},{"key":"34393_CR28","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1128\/JCM.43.7.3471-3473.2005","volume":"43","author":"EC Freundt","year":"2005","unstructured":"Freundt, E. C., Beatty, D. C., Stegall-Faulk, T. & Wright, S. M. Possible Tick-Borne Human Enterovirus Resulting in Aseptic Meningitis. J Clin Microbiol. 43, 3471\u20133473 (2005).","journal-title":"J Clin Microbiol."},{"key":"34393_CR29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4236\/ojmm.2015.53018","volume":"5","author":"A Smith","year":"2015","unstructured":"Smith, A., Oertle, J., Warren, D. & Prato, D. Chronic Lyme Disease Complex and Its Commonly Undiagnosed Primary and Secondary Co-Infections. Open J Medical Microbiol. 5, 143\u2013158 (2015).","journal-title":"Open J Medical Microbiol."},{"key":"34393_CR30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.RHU.0000062510.04724.07","volume":"9","author":"E Eskow","year":"2003","unstructured":"Eskow, E., Adelson, M. E., Rao, R.-V. S. & Mordechai, E. Evidence for Disseminated Mycoplasma fermentans in New Jersey Residents with Antecedent Tick Attachment and Subsequent Musculoskeletal Symptoms. J Clin Rheumatol. 9, 77 (2003).","journal-title":"J Clin Rheumatol."},{"key":"34393_CR31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/jamaophthalmol.2013.586","volume":"131","author":"EM Liu","year":"2013","unstructured":"Liu, E. M. & Janigian, R. H. Mycoplasma pneumoniae: The Other Masquerader. Jama Ophthalmol. 131, 251\u2013253 (2013).","journal-title":"Jama Ophthalmol."},{"key":"34393_CR32","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.micinf.2016.04.002","volume":"18","author":"L Meril\u00e4inen","year":"2016","unstructured":"Meril\u00e4inen, L., Brander, H., Herranen, A., Schwarzbach, A. & Gilbert, L. Pleomorphic forms of Borrelia burgdorferi induce distinct immune responses. Microbes Infect. 18, 484\u2013495 (2016).","journal-title":"Microbes Infect."},{"key":"34393_CR33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1099\/mic.0.000027","volume":"161","author":"L Meril\u00e4inen","year":"2015","unstructured":"Meril\u00e4inen, L., Herranen, A., Schwarzbach, A. & Gilbert, L. Morphological and biochemical features of Borrelia burgdorferi pleomorphic forms. Microbiology. 161, 516\u2013527 (2015).","journal-title":"Microbiology."},{"key":"34393_CR34","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.mehy.2006.04.025","volume":"67","author":"AB MacDonald","year":"2006","unstructured":"MacDonald, A. B. Spirochetal cyst forms in neurodegenerative disorders, hiding in plain sight. Med Hypotheses. 67, 819\u201332 (2006).","journal-title":"Med Hypotheses."},{"key":"34393_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-5-40","volume":"5","author":"J Miklossy","year":"2008","unstructured":"Miklossy, J. et al. Persisting atypical and cystic forms of Borrelia burgdorferiand local inflammation in Lyme neuroborreliosis. J Neuroinflammation. 5, 1\u201318 (2008).","journal-title":"J Neuroinflammation."},{"key":"34393_CR36","first-page":"590","volume":"44","author":"Centers for Disease Control and Prevention (CDC)","year":"1995","unstructured":"Centers for Disease Control and Prevention (CDC). Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR. 44, 590\u20131 (1995).","journal-title":"MMWR."},{"key":"34393_CR37","doi-asserted-by":"crossref","unstructured":"Halperin, J. J. Lyme Disease: An Evidence-based Approach. 296 (CABI, 2011).","DOI":"10.1079\/9781845938048.0000"},{"key":"34393_CR38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/CMR.18.3.484-509.2005","volume":"18","author":"ME Aguero-Rosenfeld","year":"2005","unstructured":"Aguero-Rosenfeld, M. E., Wang, G., Schwartz, I. & Wormser, G. P. Diagnosis of lyme borreliosis. Clin Microbiol Rev. 18, 484\u2013509 (2005).","journal-title":"Clin Microbiol Rev."},{"key":"34393_CR39","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.7717\/peerj.322","volume":"2","author":"L Johnson","year":"2014","unstructured":"Johnson, L., Wilcox, S., Mankoff, J. & Stricker, R. Severity of chronic Lyme disease compared to other chronic conditions: a quality of life survey. PeerJ. 2, e322 (2014).","journal-title":"PeerJ."},{"key":"34393_CR40","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-9-79","volume":"9","author":"J Aucott","year":"2009","unstructured":"Aucott, J. et al. Diagnostic challenges of early Lyme disease: Lessons from a community case series. Bmc Infect Dis. 9, 79 (2009).","journal-title":"Bmc Infect Dis."},{"key":"34393_CR41","first-page":"3158","volume":"8","author":"R Tokarz","year":"2018","unstructured":"Tokarz, R. et al. A multiplex serologic platform for diagnosis of tick-borne diseases. Sci Reports. 8, 3158 (2018).","journal-title":"Sci Reports."},{"key":"34393_CR42","first-page":"35069","volume":"6","author":"S Nayak","year":"2016","unstructured":"Nayak, S. et al. Microfluidics-based point-of-care test for serodiagnosis of Lyme Disease. Sci Reports. 6, 35069 (2016).","journal-title":"Sci Reports."},{"key":"34393_CR43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-93-1-8","volume":"93","author":"A Steere","year":"1980","unstructured":"Steere, A. et al. Lyme carditis: cardiac abnormalities of Lyme disease. Ann Intern Med. 93, 8\u201316 (1980).","journal-title":"Ann Intern Med."},{"key":"34393_CR44","first-page":"17","volume":"3","author":"D Rolla","year":"2013","unstructured":"Rolla, D., Conti, N., Ansaldo, F., Panaro, L. & Lusenti, T. Post-infectious glomerulonephritis presenting as acute renal failure in a patient with Lyme disease. J Renal Inj Prev. 3, 17\u201320 (2013).","journal-title":"J Renal Inj Prev."},{"key":"34393_CR45","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.idc.2015.02.004","volume":"29","author":"SL Arvikar","year":"2015","unstructured":"Arvikar, S. L. & Steere, A. C. Infectious Disease Clinics of North America. Infect Dis Clin North Am. 29, 269\u2013280 (2015).","journal-title":"Infect Dis Clin North Am."},{"key":"34393_CR46","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00002060-199607000-00015","volume":"75","author":"T Deltombe","year":"1996","unstructured":"Deltombe, T., Hanson, P., Boutsen, Y., Laloux, P. & Clerin, M. Lyme borreliosis neuropathy. A case report. Am J Phys Med Rehabil. 75, 314\u20136 (1996).","journal-title":"Am J Phys Med Rehabil."},{"key":"34393_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12982-015-0037-4","volume":"12","author":"KM Fedak","year":"2015","unstructured":"Fedak, K. M., Bernal, A., Capshaw, Z. A. & Gross, S. Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology. Emerg Themes Epidemiol. 12, 1\u20139 (2015).","journal-title":"Emerg Themes Epidemiol."},{"key":"34393_CR48","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.idc.2015.02.006","volume":"29","author":"PM Lantos","year":"2015","unstructured":"Lantos, P. M. Infectious Disease Clinics of North America. Infect Dis Clin North Am. 29, 325\u2013340 (2015).","journal-title":"Infect Dis Clin North Am."},{"key":"34393_CR49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3201\/eid1202.050765","volume":"12","author":"M Loebermann","year":"2006","unstructured":"Loebermann, M., Fingerle, V., Lademann, M., Fritzsche, C. & Reisinger, E. Borrelia burgdorferi and Anaplasma phagocytophilum Coinfection. Emerg Infect Dis. 12, 353\u2013355 (2006).","journal-title":"Emerg Infect Dis."},{"key":"34393_CR50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/00365540110080061","volume":"34","author":"A Bj\u00f6ersdorff","year":"2009","unstructured":"Bj\u00f6ersdorff, A., Wittesj\u00f6, B., Berglund, J., Massung, R. & Eliasson, I. Human Granulocytic Ehrlichiosis as a Common Cause of Tick-associated Fever in Southeast Sweden: Report from a Prospective Clinical Study. Scand J Infect Dis. 34, 187\u2013191 (2009).","journal-title":"Scand J Infect Dis."},{"key":"34393_CR51","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0140-6736(95)92502-3","volume":"346","author":"K Sumption","year":"1995","unstructured":"Sumption, K., Wright, D., Cutler, S. & Dale, B. Human ehrlichiosis in the UK. Lancet. 346, 1487\u20131488 (1995).","journal-title":"Lancet."},{"key":"34393_CR52","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3389\/fpsyg.2013.00863","volume":"4","author":"D Lakens","year":"2013","unstructured":"Lakens, D. Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol. 4, 863 (2013).","journal-title":"Front Psychol."},{"key":"34393_CR53","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1037\/0033-2909.111.2.361","volume":"111","author":"KO McGraw","year":"1992","unstructured":"McGraw, K. O. & Wong, S. A common language effect size statistic. Psychol Bulletin. 111, 361\u2013365 (1992).","journal-title":"Psychol Bulletin."},{"key":"34393_CR54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(05)70155-0","volume":"365","author":"K Brogden","year":"2005","unstructured":"Brogden, K., Guthmiller, J. & Taylor, C. Human polymicrobial infections. Lancet. 365, 253\u20135 (2005).","journal-title":"Lancet."},{"key":"34393_CR55","doi-asserted-by":"crossref","first-page":"e0005681","DOI":"10.1371\/journal.pntd.0005681","volume":"11","author":"S Karim","year":"2017","unstructured":"Karim, S. et al. A study of ticks and tick-borne livestock pathogens in Pakistan. PloS Neglect Trop Dis. 11, e0005681 (2017).","journal-title":"PloS Neglect Trop Dis."},{"key":"34393_CR56","doi-asserted-by":"crossref","first-page":"e0004539","DOI":"10.1371\/journal.pntd.0004539","volume":"10","author":"S Moutailler","year":"2016","unstructured":"Moutailler, S. et al. Co-infection of Ticks: The Rule Rather Than the Exception. PloS Neglect Trop Dis. 10, e0004539 (2016).","journal-title":"PloS Neglect Trop Dis."},{"key":"34393_CR57","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13071-017-2550-5","volume":"11","author":"TL Greay","year":"2018","unstructured":"Greay, T. L. et al. Recent insights into the tick microbiome gained through next-generation sequencing. Parasit Vector. 11, 12 (2018).","journal-title":"Parasit Vector."},{"key":"34393_CR58","doi-asserted-by":"crossref","first-page":"e103961","DOI":"10.1371\/journal.pone.0103961","volume":"9","author":"Y Qiu","year":"2014","unstructured":"Qiu, Y., Nakao, R., Ohnuma, A., Kawamori, F. & Sugimoto, C. Microbial Population Analysis of the Salivary Glands of Ticks; A Possible Strategy for the Surveillance of Bacterial Pathogens. PloS One. 9, e103961 (2014).","journal-title":"PloS One."},{"key":"34393_CR59","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/microorganisms4030028","volume":"4","author":"K Hokynar","year":"2016","unstructured":"Hokynar, K. et al. Chlamydia-Like Organisms (CLOs) in Finnish Ixodes ricinus Ticks and Human Skin. Microorganisms. 4, 28 (2016).","journal-title":"Microorganisms."},{"key":"34393_CR60","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-0757.1994.tb00019.x","volume":"5","author":"M Wec","year":"1994","unstructured":"Wec, M. & Lvh, M. The bacteria of periodontal diseases. Periodontol 2000. 5, 66\u201377 (1994).","journal-title":"Periodontol 2000."},{"key":"34393_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-9-1","volume":"9","author":"M Debiaggi","year":"2012","unstructured":"Debiaggi, M., Canducci, F., Ceresola, E. & Clementi, M. The role of infections and coinfections with newly identified and emerging respiratory viruses in children. Virol J. 9, 1\u201318 (2012).","journal-title":"Virol J."},{"key":"34393_CR62","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0738-081X(93)90090-Y","volume":"11","author":"B Berger","year":"1993","unstructured":"Berger, B. Erythema migrans. Clin Dermatol. 11, 359\u201362 (1993).","journal-title":"Clin Dermatol."},{"key":"34393_CR63","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1086\/322669","volume":"33","author":"R Kalish","year":"2001","unstructured":"Kalish, R. et al. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10\u201320 years after active Lyme disease. Clin Infect Dis. 33, 780\u20135 (2001).","journal-title":"Clin Infect Dis."},{"key":"34393_CR64","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1128\/jcm.35.3.774-776.1997","volume":"35","author":"E Hilton","year":"1997","unstructured":"Hilton, E., Tramontano, A., DeVoti, J. & Sood, S. Temporal study of immunoglobin M seroreactivity to Borrelia burgdorferi in patients treated for Lyme borreliosis. J Clin Microbiol. 35, 774\u20136 (1997).","journal-title":"J Clin Microbiol."},{"key":"34393_CR65","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/00365549409011804","volume":"26","author":"S Hammers-Berggren","year":"1994","unstructured":"Hammers-Berggren, S. et al. Serological follow-up after treatment of Borrelia arthritis and acrodermatitis chronica atrophicans. Scand J Infect Dis. 26, 339\u201347 (1994).","journal-title":"Scand J Infect Dis."},{"key":"34393_CR66","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/000155500459312","volume":"80","author":"H Lomholt","year":"2000","unstructured":"Lomholt, H., Lebech, A., Hansen, K., Brandrup, F. & Halkier-S\u00f8rensen, L. Long-term serological follow-up of patients treated for chronic cutaneous borreliosis or culture-positive erythema migrans. Acta Derm Venereol. 80, 362\u20136 (2000).","journal-title":"Acta Derm Venereol."},{"key":"34393_CR67","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1128\/iai.59.3.1050-1056.1991","volume":"59","author":"S Baig","year":"1991","unstructured":"Baig, S., Olsson, T., Hansen, K. & Link, H. Anti-Borrelia burgdorferi antibody response over the course of Lyme neuroborreliosis. Infect Immun. 59, 1050\u20136 (1991).","journal-title":"Infect Immun."},{"key":"34393_CR68","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1177\/0013164496056005002","volume":"56","author":"R Kirk","year":"1996","unstructured":"Kirk, R. Practical Significance: A Concept Whose Time Has Come. Educ Psychol Meas. 56, 746\u2013759 (1996).","journal-title":"Educ Psychol Meas."},{"key":"34393_CR69","doi-asserted-by":"crossref","first-page":"e0116767","DOI":"10.1371\/journal.pone.0116767","volume":"10","author":"E Adrion","year":"2015","unstructured":"Adrion, E., Aucott, J., Lemke, K. & Weiner, J. Health care costs, utilization and patterns of care following Lyme disease. PloS One. 10, e0116767 (2015).","journal-title":"PloS One."},{"key":"34393_CR70","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ttbdis.2015.10.005","volume":"7","author":"N Connally","year":"2016","unstructured":"Connally, N. et al. Testing practices and volume of non-Lyme tickborne diseases in the United States. Ticks Tick Borne Dis. 7, 193\u2013198 (2016).","journal-title":"Ticks Tick Borne Dis."},{"key":"34393_CR71","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2147\/IJGM.S122313","volume":"9","author":"M Cook","year":"2016","unstructured":"Cook, M. & Puri, B. Commercial test kits for detection of Lyme borreliosis: a meta-analysis of test accuracy. Int J Gen Medicine. 9, 427\u2013440 (2016).","journal-title":"Int J Gen Medicine."},{"key":"34393_CR72","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-0691.2010.03175.x","volume":"17","author":"G Stanek","year":"2011","unstructured":"Stanek, G. et al. Lyme borreliosis: Clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infec. 17, 69\u201379 (2011).","journal-title":"Clin Microbiol Infec."},{"key":"34393_CR73","first-page":"w14353","volume":"146","author":"J Nemeth","year":"2016","unstructured":"Nemeth, J. et al. Update of the Swiss guidelines on post-treatment Lyme disease syndrome. Swiss Med Wkly. 146, w14353 (2016).","journal-title":"Swiss Med Wkly."},{"key":"34393_CR74","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","volume":"43","author":"GP Wormser","year":"2006","unstructured":"Wormser, G. P. et al. The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 43, 1089\u20131134 (2006).","journal-title":"Clin Infect Dis."},{"key":"34393_CR75","doi-asserted-by":"crossref","unstructured":"Von Baehr, V., Doebis, C., Volk, H.-D. & Baehr, R. The Lymphocyte Transformation Test for Borrelia Detects Active Lyme Borreliosis and Verifies Effective Antibiotic Treatment. Open Neurol J. 6, 104\u2013112.","DOI":"10.2174\/1874205X01206010104"},{"key":"34393_CR76","first-page":"5890","volume":"7","author":"BK Puri","year":"2014","unstructured":"Puri, B. K., Segal, D. & Monro, J. A. Diagnostic use of the lymphocyte transformation test-memory lymphocyte immunostimulation assay in confirming active Lyme borreliosis in clinically and serologically ambiguous cases. Int J Clin Exp Med. 7, 5890\u20132 (2014).","journal-title":"Int J Clin Exp Med."},{"key":"34393_CR77","first-page":"1169","volume":"22","author":"A Moore","year":"2016","unstructured":"Moore, A., Nelson, C., Molins, C., Mead, P. & Schriefer, M. Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States. Emerg Infect Dis. 22, 1169\u20131177 (2016).","journal-title":"Emerg Infect Dis."},{"key":"34393_CR78","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1208\/s12248-013-9552-9","volume":"16","author":"S Dudal","year":"2014","unstructured":"Dudal, S. et al. Assay formats: Recommendation for best practices and harmonization from the global bioanalysis consortium harmonization team. AAPS J. 16, 194\u2013205 (2014).","journal-title":"AAPS J."},{"key":"34393_CR79","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1590\/0074-02760160119","volume":"111","author":"F Lardeux","year":"2016","unstructured":"Lardeux, F., Torrico, G. & Aliaga, C. Calculation of the ELISA\u2019s cut-off based on the change-point analysis method for detection of Trypanosoma cruzi infection in Bolivian dogs in the absence of controls. Mem Inst Oswaldo Cruz. 111, 501\u20134 (2016).","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"34393_CR80","doi-asserted-by":"crossref","unstructured":"Crowther, J. R. The ELISA Guidebook. Methods Mol Biol. 149, 415 (Humana Press Inc, 2000).","DOI":"10.1385\/1592590497"},{"key":"34393_CR81","unstructured":"Van Emon, J. M., Chuang, J. C., Dill, K., Xiong, G. & Ambrus, \u00c1. Analysis of Pesticides in Food and Environmental Samples. 384 (CRC Press, 2008)."},{"key":"34393_CR82","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1128\/CVI.00341-09","volume":"17","author":"T Cerar","year":"2010","unstructured":"Cerar, T., Ogrinc, K., Strle, F. & Ru\u017ei\u0107-Sablji\u0107, E. Humoral Immune Responses in Patients with Lyme Neuroborreliosis. Clin Vaccine Immunol. 17, 645\u2013650 (2010).","journal-title":"Clin Vaccine Immunol."},{"key":"34393_CR83","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/BF01713052","volume":"24","author":"H Hofmann","year":"1996","unstructured":"Hofmann, H. Lyme borreliosis-problems of serological diagnosis. Infection. 24, 470\u20132 (1996).","journal-title":"Infection."},{"key":"34393_CR84","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000213075","volume":"37","author":"R Mullegger","year":"2009","unstructured":"Mullegger, R. & Glatz, M. Is serological follow-up useful for patients with cutaneous Lyme borreliosis? Curr Probl dermatol. 37, 178\u201382 (2009).","journal-title":"Curr Probl dermatol."},{"key":"34393_CR85","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/jcm.32.6.1519-1525.1994","volume":"32","author":"S Hammers-Berggren","year":"1994","unstructured":"Hammers-Berggren, S. et al. Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis. J Clin Microbiol. 32, 1519\u201325 (1994).","journal-title":"J Clin Microbiol."},{"key":"34393_CR86","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-3083.1993.tb02566.x","volume":"37","author":"Z Wang","year":"1993","unstructured":"Wang, Z., Hansen, K., Sid\u00e9n, A. & Cruz, M. Intrathecal synthesis of anti-Borrelia burgdorferi antibodies in neuroborreliosis: a study with special emphasis on oligoclonal IgM antibody bands. Scand J Immunol. 37, 369\u201376 (1993).","journal-title":"Scand J Immunol."},{"key":"34393_CR87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2012\/719821","volume":"2012","author":"E Aberer","year":"2012","unstructured":"Aberer, E. & Schwantzer, G. Course of Antibody Response in Lyme Borreliosis Patients before and after Therapy. ISRN Immunol. 2012, 1\u20134 (2012).","journal-title":"ISRN Immunol."},{"key":"34393_CR88","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1086\/374376","volume":"187","author":"M Peltomaa","year":"2003","unstructured":"Peltomaa, M., McHugh, G. & Steere, A. C. Persistence of the antibody response to the VlsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease. J Infect Dis. 187, 1178\u201386 (2003).","journal-title":"J Infect Dis."},{"key":"34393_CR89","first-page":"41","volume":"3","author":"LA Karaivanova","year":"1997","unstructured":"Karaivanova, L. A., Tsenova, L. G. & Zarcheva, V. D. Early Lyme disease: Humoral immune status and treatment. Clin Infect Dis. 3, 41\u201344 (1997).","journal-title":"Clin Infect Dis."},{"key":"34393_CR90","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archderm.142.7.862","volume":"142","author":"M Glatz","year":"2006","unstructured":"Glatz, M., Golestani, M., Kerl, H. & M\u00fcllegger, R. R. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients. Arch Dermatol. 142, 862\u20138 (2006).","journal-title":"Arch Dermatol."},{"key":"34393_CR91","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2340\/0001555565509514","volume":"65","author":"E Asbrink","year":"1985","unstructured":"Asbrink, E., Hovmark, A. & Hederstedt, B. Serologic studies of erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans with indirect immunofluorescence and enzyme-linked immunosorbent assays. Acta Derm Venereol. 65, 509\u201314 (1985).","journal-title":"Acta Derm Venereol."},{"key":"34393_CR92","doi-asserted-by":"crossref","first-page":"486","DOI":"10.5812\/ijem.3505","volume":"10","author":"A Ghasemi","year":"2012","unstructured":"Ghasemi, A. & Zahediasl, S. Normality Tests for Statistical Analysis: A Guide for Non-Statisticians. Int J Endocrinol Metab. 10, 486\u2013489 (2012).","journal-title":"Int J Endocrinol Metab."},{"key":"34393_CR93","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4300\/JGME-D-12-00156.1","volume":"4","author":"GM Sullivan","year":"2012","unstructured":"Sullivan, G. M. & Feinn, R. Using Effect Size\u2014or Why the P Value Is Not Enough. J Grad Med Educ. 4, 279\u2013282 (2012).","journal-title":"J Grad Med Educ."},{"key":"34393_CR94","unstructured":"Hedges, L. & Olkin, I. Statistical Methods for Meta-Analysis. 86 (New York: Academic Press, 1985)."},{"key":"34393_CR95","volume-title":"Discovering statistics using SPSS","author":"A Field","year":"2009","unstructured":"Field, A. Discovering statistics using SPSS. (SAGE, London, 2009)."},{"key":"34393_CR96","first-page":"1235","volume":"9","author":"GF Reed","year":"2002","unstructured":"Reed, G. F., Lynn, F. & Meade, B. D. Use of coefficient of variation in assessing variability of quantitative assays. Clin Diagn Lab Immunol. 9, 1235\u20139 (2002).","journal-title":"Clin Diagn Lab Immunol."},{"key":"34393_CR97","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","volume":"39","author":"M Zweig","year":"1993","unstructured":"Zweig, M. & Campbell, G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 39, 561\u201377 (1993).","journal-title":"Clin Chem."},{"key":"34393_CR98","first-page":"627","volume":"4","author":"K Hajian-Tilaki","year":"2013","unstructured":"Hajian-Tilaki, K. Receiver Operating Characteristic (ROC) Curve Analysis for Medical Diagnostic Test Evaluation. Caspian J Intern Med. 4, 627\u201335 (2013).","journal-title":"Caspian J Intern Med."},{"key":"34393_CR99","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"J Hanley","year":"1982","unstructured":"Hanley, J. & McNeil, B. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 143, 29\u201336 (1982).","journal-title":"Radiology."},{"key":"34393_CR100","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1038\/nrmicro1523","volume":"4","author":"S Banoo","year":"2008","unstructured":"Banoo, S. et al. Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol. 4, S21\u2013S31 (2008).","journal-title":"Nat Rev Microbiol."},{"key":"34393_CR101","unstructured":"Flores, O., Schwarzch, A., Rredo, B. & Altieri, G. U. Biochip, antigen bouquet, optical reader and method for detecting and monitoring diseases. WIPO (2014)."},{"key":"34393_CR102","unstructured":"Huang, L., Hoey, J., Adelson, M. & Mordechai, E. Recombinant fragments and synthetic peptides of 17-kda polypeptide useful in detecting bartonella henselae. European Patent (2011)."},{"key":"34393_CR103","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1099\/jmm.0.069559-0","volume":"63","author":"J Zhang","year":"2014","unstructured":"Zhang, J. et al. A novel Omp25-binding peptide screened by phage display can inhibit Brucella abortus 2308 infection in vitro and in vivo. J Med Microbiol. 63, 780\u20137 (2014).","journal-title":"J Med Microbiol."},{"key":"34393_CR104","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1128\/iai.13.4.1030-1036.1976","volume":"13","author":"N Tachibana","year":"1976","unstructured":"Tachibana, N., Kusaba, T., Matsumoto, I. & Kobayashi, Y. Purification of complement-fixing antigens of Rickettsia sennetsu by ether treatment. Infect Immun. 13, 1030\u20136 (1976).","journal-title":"Infect Immun."},{"key":"34393_CR105","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1099\/0022-1317-74-9-2031","volume":"74","author":"H Holzmann","year":"1993","unstructured":"Holzmann, H. et al. Assessment of the antigenic structure of tick-borne encephalitis virus by the use of synthetic peptides. J Gen Virol. 74, 2031\u20135 (1993).","journal-title":"J Gen Virol."},{"key":"34393_CR106","unstructured":"Mitchell, W. M. & Stratton, C. W. Diagnosis and management of infection caused by chlamydia. United States Patent (1998)."},{"key":"34393_CR107","unstructured":"Ohana, B. Chlamydia trachomatis specific peptides and their use in diagnostic assays. United States Patent (2004)."},{"key":"34393_CR108","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.vaccine.2013.02.051","volume":"31","author":"J Shi","year":"2013","unstructured":"Shi, J., Huang, X., Liu, Q. & Huang, Z. Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16. Vaccine. 31, 2130\u20136 (2013).","journal-title":"Vaccine."},{"key":"34393_CR109","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/jcm.29.9.1868-1872.1991","volume":"29","author":"M Landini","year":"1991","unstructured":"Landini, M., Ripalti, A. K. & Pouletty, P. Human cytomegalovirus structural proteins: immune reaction against pp150 synthetic peptides. J Clinical Microbiol. 29, 1868\u201372 (1991).","journal-title":"J Clinical Microbiol."},{"key":"34393_CR110","unstructured":"Middeldorp, J. M. & van Grunsven, W. M. J. Peptides and nucleic acid sequences related to the Epstein Barr virus. United States Patent (2009)."},{"key":"34393_CR111","doi-asserted-by":"crossref","first-page":"110","DOI":"10.7150\/ijms.7.110","volume":"7","author":"V Kivovich","year":"2010","unstructured":"Kivovich, V., Gilbert, L., Vuento, M. & Naides, S. J. Parvovirus B19 genotype specific amino acid substitution in NS1 reduces the protein\u2019s cytotoxicity in culture. Int J Med Sci. 7, 110\u20139 (2010).","journal-title":"Int J Med Sci."},{"key":"34393_CR112","doi-asserted-by":"crossref","first-page":"e67179","DOI":"10.1371\/journal.pone.0067179","volume":"8","author":"K Thammasri","year":"2013","unstructured":"Thammasri, K. et al. Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells. PloS One. 8, e67179 (2013).","journal-title":"PloS One."},{"key":"34393_CR113","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1128\/jcm.28.6.1194-1197.1990","volume":"28","author":"E Jacobs","year":"1990","unstructured":"Jacobs, E., Pilatschek, A., Gerstenecker, B., Oberle, K. & Bredt, W. Immunodominant epitopes of the adhesin of Mycoplasma pneumoniae. J Clin Microbiol. 28, 1194\u20137 (1990).","journal-title":"J Clin Microbiol."},{"key":"34393_CR114","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1128\/iai.64.5.1800-1809.1996","volume":"64","author":"P Theiss","year":"1996","unstructured":"Theiss, P., Karpas, A. & Wise, K. Antigenic topology of the P29 surface lipoprotein of Mycoplasma fermentans: differential display of epitopes results in high-frequency phase variation. Infect Immun. 64, 1800\u20139 (1996).","journal-title":"Infect Immun."}],"updated-by":[{"DOI":"10.1038\/s41598-022-07207-2","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"record-id":"35601"},{"DOI":"10.1038\/s41598-018-34393-9","type":"expression_of_concern","label":"Expression of concern","source":"retraction-watch","updated":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"record-id":"35602"},{"DOI":"10.1038\/s41598-022-07207-2","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34393-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34393-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34393-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T08:23:41Z","timestamp":1693988621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34393-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,29]]},"references-count":114,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["34393"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-34393-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,29]]},"assertion":[{"value":"11 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Editor\u2019s Note: Readers are alerted that the reliability of data presented in this manuscript is currently in question. Further editorial action may be taken as appropriate once the investigation into the concerns is complete and all parties have been given an opportunity to respond in full.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-022-07207-2","URL":"https:\/\/doi.org\/10.1038\/s41598-022-07207-2","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Yes, the authors have competing interests as defined by Nature Research, or other interests that might be perceived to influence the results and\/or discussion reported in this paper. Following Nature Research policy authors of this manuscript have the following competing interests, K.G., L.M. and L.G. have a financial and business interest in Te?ted Oy. O.F., H.P., M.Q.-D. and S.C. have no commercial or financial relationships that could be construed as a potential conflict of interest. Funding sources mentioned in the acknowledgment section and Te?ted Oy had no role in experimental design, reporting of the results, or the decision to publish. K.G., L.M., O.F., H.P., M.Q.-D., S.C. and L.G. do not have any non-financial competing interests to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15932"}}